| Role |
Name |
Disclosure |
Details |
| Author | Chad M Hivnor, MD, Chief, Outpatient and Pediatric Dermatology, Dermatology Clinic; San Antonio Unified Services Health Education Consortium; Lackland Air Force Base, Texas | Nothing to disclose | Details | | Coauthor | Wendi E Wohltmann, MD, Dermatology Resident, San Antonio Uniformed Health Sciences Education Consortium, Wilford Hall Medical Center, Lackland Air Force Base | Nothing to disclose | Details | | Medical Editor | Takeji Nishikawa, MD, Emeritus Professor, Department of Dermatology, Keio University School of Medicine; Director, Samoncho Dermatology Clinic; Managing Director, The Waksman Foundation of Japan Inc | Nothing to disclose | Details | | Pharmacy Editor | David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic | 3M Pharmaceutical Graceway Pharmaceuticals | Details | | Managing Editor | Rosalie Elenitsas, MD, Associate Professor of Dermatology, University of Pennsylvania School of Medicine; Director, Penn Cutaneous Pathology Services, Department of Dermatology, University of Pennsylvania Health System | Nothing to disclose | Details | | CME Editor | Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania | AMGEN AMGEN Genentech Centocor Centocor Covance Shire | Details | | Chief Editor | Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Takeji Nishikawa, Medical Editor |
The contributor discloses no conflict of interest. |
|